Global PMP22 Antibody Supply, Demand and Key Producers, 2023-2029

Description

The global PMP22 Antibody market size is expected to reach $ 28 million by 2029, rising at a market growth of 19.1% CAGR during the forecast period (2023-2029).

According to International Telecommunication Union (ITU), the global Internet users (online population) were more than 5 billion. And the number of online shoppers was also increasing. In 2022, the global e-commerce market penetration rate increased to 19.7%, and the e-commerce market reached $5.5 trillion. At the same time, the Asian e-commerce market ranked at the top of the revenue ranking, which has reached $1.8 trillion. According to the National Bureau of Statistics, China was the largest online retail market in 2022, with online retail sales of 13.79 trillion yuan and a year-on-year increase of 4%. Among them, the online retail sales of physical goods were 11.96 trillion yuan, with a year-on-year increase of 6.2%, which accounted for 27.2% of the total retail sales of consumer goods.

Antibodies are proteins that protect you when an unwanted substance enters your body.

This report studies the global PMP22 Antibody demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for PMP22 Antibody, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of PMP22 Antibody that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global PMP22 Antibody total market, 2018-2029, (USD Million)
Global PMP22 Antibody total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: PMP22 Antibody total market, key domestic companies and share, (USD Million)
Global PMP22 Antibody revenue by player and market share 2018-2023, (USD Million)
Global PMP22 Antibody total market by Type, CAGR, 2018-2029, (USD Million)
Global PMP22 Antibody total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global PMP22 Antibody market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Santa Cruz Biotechnology, FineTest, Merck, LSBio, United States Biological, Boster Biological Technology, Biorbyt, BioLegend and EXBIO, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PMP22 Antibody market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global PMP22 Antibody Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global PMP22 Antibody Market, Segmentation by Type
    Polyclonal
    Monoclonal

Global PMP22 Antibody Market, Segmentation by Application
    Flow Cytometry
    Immunofluorescence
    Immunohistochemistry Frozen
    Immunohistochemistry Paraffin
    Western Blot
    Others

Companies Profiled:
    Santa Cruz Biotechnology
    FineTest
    Merck
    LSBio
    United States Biological
    Boster Biological Technology
    Biorbyt
    BioLegend
    EXBIO

Key Questions Answered
1. How big is the global PMP22 Antibody market?
2. What is the demand of the global PMP22 Antibody market?
3. What is the year over year growth of the global PMP22 Antibody market?
4. What is the total value of the global PMP22 Antibody market?
5. Who are the major players in the global PMP22 Antibody market?

Table of Contents

1 Supply Summary
    1.1 PMP22 Antibody Introduction
    1.2 World PMP22 Antibody Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World PMP22 Antibody Total Market by Region (by Headquarter Location)
        1.3.1 World PMP22 Antibody Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States PMP22 Antibody Market Size (2018-2029)
        1.3.3 China PMP22 Antibody Market Size (2018-2029)
        1.3.4 Europe PMP22 Antibody Market Size (2018-2029)
        1.3.5 Japan PMP22 Antibody Market Size (2018-2029)
        1.3.6 South Korea PMP22 Antibody Market Size (2018-2029)
        1.3.7 ASEAN PMP22 Antibody Market Size (2018-2029)
        1.3.8 India PMP22 Antibody Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 PMP22 Antibody Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 PMP22 Antibody Major Market Trends

2 Demand Summary
    2.1 World PMP22 Antibody Consumption Value (2018-2029)
    2.2 World PMP22 Antibody Consumption Value by Region
        2.2.1 World PMP22 Antibody Consumption Value by Region (2018-2023)
        2.2.2 World PMP22 Antibody Consumption Value Forecast by Region (2024-2029)
    2.3 United States PMP22 Antibody Consumption Value (2018-2029)
    2.4 China PMP22 Antibody Consumption Value (2018-2029)
    2.5 Europe PMP22 Antibody Consumption Value (2018-2029)
    2.6 Japan PMP22 Antibody Consumption Value (2018-2029)
    2.7 South Korea PMP22 Antibody Consumption Value (2018-2029)
    2.8 ASEAN PMP22 Antibody Consumption Value (2018-2029)
    2.9 India PMP22 Antibody Consumption Value (2018-2029)

3 World PMP22 Antibody Companies Competitive Analysis
    3.1 World PMP22 Antibody Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global PMP22 Antibody Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for PMP22 Antibody in 2022
        3.2.3 Global Concentration Ratios (CR8) for PMP22 Antibody in 2022
    3.3 PMP22 Antibody Company Evaluation Quadrant
    3.4 PMP22 Antibody Market: Overall Company Footprint Analysis
        3.4.1 PMP22 Antibody Market: Region Footprint
        3.4.2 PMP22 Antibody Market: Company Product Type Footprint
        3.4.3 PMP22 Antibody Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: PMP22 Antibody Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: PMP22 Antibody Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: PMP22 Antibody Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: PMP22 Antibody Consumption Value Comparison
        4.2.1 United States VS China: PMP22 Antibody Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: PMP22 Antibody Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based PMP22 Antibody Companies and Market Share, 2018-2023
        4.3.1 United States Based PMP22 Antibody Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies PMP22 Antibody Revenue, (2018-2023)
    4.4 China Based Companies PMP22 Antibody Revenue and Market Share, 2018-2023
        4.4.1 China Based PMP22 Antibody Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies PMP22 Antibody Revenue, (2018-2023)
    4.5 Rest of World Based PMP22 Antibody Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based PMP22 Antibody Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies PMP22 Antibody Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World PMP22 Antibody Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Polyclonal
        5.2.2 Monoclonal
    5.3 Market Segment by Type
        5.3.1 World PMP22 Antibody Market Size by Type (2018-2023)
        5.3.2 World PMP22 Antibody Market Size by Type (2024-2029)
        5.3.3 World PMP22 Antibody Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World PMP22 Antibody Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Flow Cytometry
        6.2.2 Immunofluorescence
        6.2.3 Immunohistochemistry Frozen
        6.2.4 Immunohistochemistry Paraffin
        6.2.5 Immunohistochemistry Paraffin
        6.2.6 Others
    6.3 Market Segment by Application
        6.3.1 World PMP22 Antibody Market Size by Application (2018-2023)
        6.3.2 World PMP22 Antibody Market Size by Application (2024-2029)
        6.3.3 World PMP22 Antibody Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Santa Cruz Biotechnology
        7.1.1 Santa Cruz Biotechnology Details
        7.1.2 Santa Cruz Biotechnology Major Business
        7.1.3 Santa Cruz Biotechnology PMP22 Antibody Product and Services
        7.1.4 Santa Cruz Biotechnology PMP22 Antibody Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Santa Cruz Biotechnology Recent Developments/Updates
        7.1.6 Santa Cruz Biotechnology Competitive Strengths & Weaknesses
    7.2 FineTest
        7.2.1 FineTest Details
        7.2.2 FineTest Major Business
        7.2.3 FineTest PMP22 Antibody Product and Services
        7.2.4 FineTest PMP22 Antibody Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 FineTest Recent Developments/Updates
        7.2.6 FineTest Competitive Strengths & Weaknesses
    7.3 Merck
        7.3.1 Merck Details
        7.3.2 Merck Major Business
        7.3.3 Merck PMP22 Antibody Product and Services
        7.3.4 Merck PMP22 Antibody Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Merck Recent Developments/Updates
        7.3.6 Merck Competitive Strengths & Weaknesses
    7.4 LSBio
        7.4.1 LSBio Details
        7.4.2 LSBio Major Business
        7.4.3 LSBio PMP22 Antibody Product and Services
        7.4.4 LSBio PMP22 Antibody Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 LSBio Recent Developments/Updates
        7.4.6 LSBio Competitive Strengths & Weaknesses
    7.5 United States Biological
        7.5.1 United States Biological Details
        7.5.2 United States Biological Major Business
        7.5.3 United States Biological PMP22 Antibody Product and Services
        7.5.4 United States Biological PMP22 Antibody Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 United States Biological Recent Developments/Updates
        7.5.6 United States Biological Competitive Strengths & Weaknesses
    7.6 Boster Biological Technology
        7.6.1 Boster Biological Technology Details
        7.6.2 Boster Biological Technology Major Business
        7.6.3 Boster Biological Technology PMP22 Antibody Product and Services
        7.6.4 Boster Biological Technology PMP22 Antibody Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Boster Biological Technology Recent Developments/Updates
        7.6.6 Boster Biological Technology Competitive Strengths & Weaknesses
    7.7 Biorbyt
        7.7.1 Biorbyt Details
        7.7.2 Biorbyt Major Business
        7.7.3 Biorbyt PMP22 Antibody Product and Services
        7.7.4 Biorbyt PMP22 Antibody Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Biorbyt Recent Developments/Updates
        7.7.6 Biorbyt Competitive Strengths & Weaknesses
    7.8 BioLegend
        7.8.1 BioLegend Details
        7.8.2 BioLegend Major Business
        7.8.3 BioLegend PMP22 Antibody Product and Services
        7.8.4 BioLegend PMP22 Antibody Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 BioLegend Recent Developments/Updates
        7.8.6 BioLegend Competitive Strengths & Weaknesses
    7.9 EXBIO
        7.9.1 EXBIO Details
        7.9.2 EXBIO Major Business
        7.9.3 EXBIO PMP22 Antibody Product and Services
        7.9.4 EXBIO PMP22 Antibody Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 EXBIO Recent Developments/Updates
        7.9.6 EXBIO Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 PMP22 Antibody Industry Chain
    8.2 PMP22 Antibody Upstream Analysis
    8.3 PMP22 Antibody Midstream Analysis
    8.4 PMP22 Antibody Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World PMP22 Antibody Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World PMP22 Antibody Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World PMP22 Antibody Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World PMP22 Antibody Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World PMP22 Antibody Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World PMP22 Antibody Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World PMP22 Antibody Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World PMP22 Antibody Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World PMP22 Antibody Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key PMP22 Antibody Players in 2022
    Table 12. World PMP22 Antibody Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global PMP22 Antibody Company Evaluation Quadrant
    Table 14. Head Office of Key PMP22 Antibody Player
    Table 15. PMP22 Antibody Market: Company Product Type Footprint
    Table 16. PMP22 Antibody Market: Company Product Application Footprint
    Table 17. PMP22 Antibody Mergers & Acquisitions Activity
    Table 18. United States VS China PMP22 Antibody Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China PMP22 Antibody Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based PMP22 Antibody Companies, Headquarters (States, Country)
    Table 21. United States Based Companies PMP22 Antibody Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies PMP22 Antibody Revenue Market Share (2018-2023)
    Table 23. China Based PMP22 Antibody Companies, Headquarters (Province, Country)
    Table 24. China Based Companies PMP22 Antibody Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies PMP22 Antibody Revenue Market Share (2018-2023)
    Table 26. Rest of World Based PMP22 Antibody Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies PMP22 Antibody Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies PMP22 Antibody Revenue Market Share (2018-2023)
    Table 29. World PMP22 Antibody Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World PMP22 Antibody Market Size by Type (2018-2023) & (USD Million)
    Table 31. World PMP22 Antibody Market Size by Type (2024-2029) & (USD Million)
    Table 32. World PMP22 Antibody Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World PMP22 Antibody Market Size by Application (2018-2023) & (USD Million)
    Table 34. World PMP22 Antibody Market Size by Application (2024-2029) & (USD Million)
    Table 35. Santa Cruz Biotechnology Basic Information, Area Served and Competitors
    Table 36. Santa Cruz Biotechnology Major Business
    Table 37. Santa Cruz Biotechnology PMP22 Antibody Product and Services
    Table 38. Santa Cruz Biotechnology PMP22 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Santa Cruz Biotechnology Recent Developments/Updates
    Table 40. Santa Cruz Biotechnology Competitive Strengths & Weaknesses
    Table 41. FineTest Basic Information, Area Served and Competitors
    Table 42. FineTest Major Business
    Table 43. FineTest PMP22 Antibody Product and Services
    Table 44. FineTest PMP22 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. FineTest Recent Developments/Updates
    Table 46. FineTest Competitive Strengths & Weaknesses
    Table 47. Merck Basic Information, Area Served and Competitors
    Table 48. Merck Major Business
    Table 49. Merck PMP22 Antibody Product and Services
    Table 50. Merck PMP22 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Merck Recent Developments/Updates
    Table 52. Merck Competitive Strengths & Weaknesses
    Table 53. LSBio Basic Information, Area Served and Competitors
    Table 54. LSBio Major Business
    Table 55. LSBio PMP22 Antibody Product and Services
    Table 56. LSBio PMP22 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. LSBio Recent Developments/Updates
    Table 58. LSBio Competitive Strengths & Weaknesses
    Table 59. United States Biological Basic Information, Area Served and Competitors
    Table 60. United States Biological Major Business
    Table 61. United States Biological PMP22 Antibody Product and Services
    Table 62. United States Biological PMP22 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. United States Biological Recent Developments/Updates
    Table 64. United States Biological Competitive Strengths & Weaknesses
    Table 65. Boster Biological Technology Basic Information, Area Served and Competitors
    Table 66. Boster Biological Technology Major Business
    Table 67. Boster Biological Technology PMP22 Antibody Product and Services
    Table 68. Boster Biological Technology PMP22 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Boster Biological Technology Recent Developments/Updates
    Table 70. Boster Biological Technology Competitive Strengths & Weaknesses
    Table 71. Biorbyt Basic Information, Area Served and Competitors
    Table 72. Biorbyt Major Business
    Table 73. Biorbyt PMP22 Antibody Product and Services
    Table 74. Biorbyt PMP22 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Biorbyt Recent Developments/Updates
    Table 76. Biorbyt Competitive Strengths & Weaknesses
    Table 77. BioLegend Basic Information, Area Served and Competitors
    Table 78. BioLegend Major Business
    Table 79. BioLegend PMP22 Antibody Product and Services
    Table 80. BioLegend PMP22 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. BioLegend Recent Developments/Updates
    Table 82. EXBIO Basic Information, Area Served and Competitors
    Table 83. EXBIO Major Business
    Table 84. EXBIO PMP22 Antibody Product and Services
    Table 85. EXBIO PMP22 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 86. Global Key Players of PMP22 Antibody Upstream (Raw Materials)
    Table 87. PMP22 Antibody Typical Customers
List of Figure
    Figure 1. PMP22 Antibody Picture
    Figure 2. World PMP22 Antibody Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World PMP22 Antibody Total Market Size (2018-2029) & (USD Million)
    Figure 4. World PMP22 Antibody Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World PMP22 Antibody Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company PMP22 Antibody Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company PMP22 Antibody Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company PMP22 Antibody Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company PMP22 Antibody Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company PMP22 Antibody Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company PMP22 Antibody Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company PMP22 Antibody Revenue (2018-2029) & (USD Million)
    Figure 13. PMP22 Antibody Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World PMP22 Antibody Consumption Value (2018-2029) & (USD Million)
    Figure 16. World PMP22 Antibody Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States PMP22 Antibody Consumption Value (2018-2029) & (USD Million)
    Figure 18. China PMP22 Antibody Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe PMP22 Antibody Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan PMP22 Antibody Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea PMP22 Antibody Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN PMP22 Antibody Consumption Value (2018-2029) & (USD Million)
    Figure 23. India PMP22 Antibody Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of PMP22 Antibody by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for PMP22 Antibody Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for PMP22 Antibody Markets in 2022
    Figure 27. United States VS China: PMP22 Antibody Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: PMP22 Antibody Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World PMP22 Antibody Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World PMP22 Antibody Market Size Market Share by Type in 2022
    Figure 31. Polyclonal
    Figure 32. Monoclonal
    Figure 33. World PMP22 Antibody Market Size Market Share by Type (2018-2029)
    Figure 34. World PMP22 Antibody Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World PMP22 Antibody Market Size Market Share by Application in 2022
    Figure 36. Flow Cytometry
    Figure 37. Immunofluorescence
    Figure 38. Immunohistochemistry Frozen
    Figure 39. Immunohistochemistry Paraffin
    Figure 40. Western Blot
    Figure 41. Others
    Figure 42. PMP22 Antibody Industrial Chain
    Figure 43. Methodology
    Figure 44. Research Process and Data Source

Companies Mentioned

Santa Cruz Biotechnology
FineTest
Merck
LSBio
United States Biological
Boster Biological Technology
Biorbyt
BioLegend
EXBIO